Fisher & Paykel Healthcare Corporation Limited (ASX:FPH)

ALERT: Price-sensitive ASX Announcement for FPH

Current share price for FPH : $32.930 1.27 (4.01%)⁺

Announcement

Profit Guidance

Release

23 Feb 2026 7:30AM

Price at Release

$31.660

Full Release

Summary

Fisher & Paykel Healthcare Corporation Limited updated its financial year 2026 revenue and earnings guidance, expecting operating revenue to be approximately $2.30 billion and net profit after tax to range between $450 million and $470 million. This revision reflects good growth across hospital products and efficiency gains, though it excludes potential impacts from US tariff refunds. The US Supreme Court's decision invalidating certain tariffs may affect Fisher & Paykel's costs, with further updates anticipated later. The company continues to focus on its long-term strategy and sustainable growth, ensuring these factors do not materially impact its direction.

Key Points

Fisher & Paykel Healthcare revised FY26 revenue and earnings guidance.
Expected operating revenue is approximately $2.30 billion.
Net profit after tax expected to be $450 million to $470 million.
Growth noted in hospital products and efficiency improvements.
US Supreme Court invalidated certain tariffs, impacting costs.
Company remains focused on long-term strategy and growth.

IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.